Copper Iodide Nanoparticles Immobolized Porous Polysulfonamide: An Efective Nanocatalyst…
glass plate with 0.25 mm thickness. 1H NMR and 13C NMR
spectra were recorded at 400 MHz and 100 MHz, respec-
tively, on a Bruker Avance HD apparatus in CDCl3. Chemi-
cal shifts are given on the δ-scale in ppm and residual sol-
vent peaks were used as internal standards.
6.79 (t, J=8 Hz, 1H), 7.08 (d, J=4 Hz, 2H), 7.29 (d, 8H),
7.73(s, 3H), 8.04 (s, 1H). 13C NMR (100 MHz, CDCl3)
δ:=29.5, 113.2, 118.1, 123.4, 125.3, 127.1, 127.6, 127.9,
128.1, 128.6, 129.1, 133.1, 136.2. MS: m/z=283.36 [M+].
3-Benzyl-2-(p-tolyl)imidazo[1,2-a]pyridine (5a).
M.p. 159–161 °C [24]; FT-IR (KBr) ν: 3026, 2917, 1654,
1627, 1527 cm−1; 1H NMR (400 MHz, CDCl3) δ: 2.31 (s,
3H), 4.41 (s, 2H), 6.79 (t, J=8 Hz, 1H), 7.10 (d, J=8 Hz,
2H), 7.16 (m, 2H), 7.28–7.39 (m, 5H), 7.51 (s, 2H), 7.65
(s, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ:=21.2, 29.8,
112.7, 114.57, 117.0, 123.7, 124.8, 126.9, 128.0, 128.6,
129.7, 131.5, 136.8, 137.9, 142.2, 145.0, 149.7, 152.8. MS:
m/z=298.1[M+].
2.2 General Procedure for the Synthesis
of Imidazo[1,2‑a]Pyridines
A mixture of 2-aminopyridine (1 mmol) and benzaldehyde
(1.1 mmol) was stirred in a 10 mL round bottomed fask.
After 5 min, phenylacetylene (1.2 mmol), PEA-PSA@CuI
(3.5 mol%, 0.05 g) and EtOH (2 mL) were added and, then,
the resulting mixture was stirred under refux conditions for
an appropriate reaction time. Thin-layer chromatography
(TLC) was applied to monitor the progress of the reaction.
When the reaction was completed, the catalyst was sepa-
rated by centrifugation. Afterwards, the obtained solid was
recrystallized from ethanol in order to give the pure product.
3-Benzyl-2-(3-bromophenyl)imidazo[1,2-a]pyridine
(6a). M.p. 152–154 °C [24]; FT-IR (KBr) ν: 3060, 2917,
1655, 1631, 1498 cm−1; H NMR (400 MHz, CDCl3) δ:
4.39 (s, 2H), 6.81 (t, J=4 Hz, 1H), 7.07 (d, J=8 Hz, 2H),
7.12 (s, 1H), 7.29–7.41 (m, 7H), 7.53 (d, J= 12 Hz, 2H),
7.73 (s,1H), 7.83 (s, 1H), 8.20 (s, 1H); 13C NMR (100 MHz,
CDCl3) δ:=29.1, 113.1, 114.9, 123.0, 127.1, 127.9, 128.6,
129.1, 129.3, 130.3, 130.8, 131.2, 132.0, 136.5. MS:
m/z=363.2[M+].
2.3 Analytical Data of the Products
3-Benzyl-2-(4-chlorophenyl)imidazo[1,2-a]pyridine (1a).
M.p. 142–144 °C [24]; FT-IR (KBr) ν: 3061, 2926, 1634,
1600, 1487 cm−1; 1H NMR (400 MHz, CDCl3) δ: 4.28 (s,
2H), 6.72 (s, 1H), 6.96 (d, J=4 Hz, 2H), 7.17–7.24 (m, 5H),
7.42 (s, 1H), 7.53 (s, 2H), 7.61 (s, 1H), 7.97 (d, J = 8 Hz,
1H). 13C NMR (100 MHz, CDCl3) δ:=29.7, 113.1, 115.0,
125.3, 127.1, 127.5, 127.9, 128.6, 129.1, 129.5, 129.6,
129.9, 130.2, 130.6, 130.9, 131.3, 132.0, 134.0, 136.1. MS:
m/z=318.1[M+].
3-Benzyl-2-(4-methoxyphenyl)imidazo[1,2-a]pyridine
(7a). M.p. 129–131 °C [24]; FT-IR (KBr) ν: 3058, 2932,
1633, 1600, 1505 cm−1; H NMR (400 MHz, CDCl3) δ:
3.76 (s, 3H), 4.41 (s, 2H), 6.78 (t, J = 8 Hz, 1H), 6.88 (s,
2H), 7.09 (d, J=8 Hz, 2H), 7.14 (s, 1H), 7.29 (d, J=4 Hz,
3H), 7.33 (d, J = 8 Hz, 2H), 7.66 (s, 2H), 7.97 (s, 1H),
8.46 (s, 1H); 13C NMR (100 MHz, CDCl3) δ:=30.1, 55.2,
113.1, 113.7, 115.3, 117.1, 124.9, 127.1, 129.1, 130.3,
131.8, 136.3, 141.7, 149.6, 150.1, 152.5, 159.5, 165.1. MS:
m/z=314.3[M+].
(2a). M.p. 84–87 °C [24]; FT-IR (KBr) ν: 3060, 2926, 1657,
4-(3-benzylimidazo[1,2-a]pyridin-2-yl)-N,N-dimethy-
laniline (9a). M.p. 123–126 °C [25]; FT-IR (KBr) ν: 3072,
2883, 1617, 1600, 1515, 1400 cm−1; 1H NMR (400 MHz,
CDCl3) δ: 2.96 (s, 6H), 4.47 (s, 2H), 6.71 (t, J=4 Hz, 2),
6.75 (s, 1H), 7.15 (d, J = 8 Hz, 2H), 7.24–7.33 (m, 3H),
7.70 (s, 2H); 13C NMR (100 MHz, CDCl3) δ:=30.1, 40.4,
112.1, 112.3, 123.9, 126.8, 127.7, 128.9, 137.1, 150.1. MS:
m/z=327.43[M+].
1
1634, 1501 cm−1; H NMR (400 MHz, CDCl3) δ: 4.35(s,
2H), 6.81 (s, 1H), 6.92 (s, 1H), 7.02 (s, 2H), 7.29–7.33
(m, 5H), 7.51 (s, 1H), 7.64 (s, 2H), 8.22(s, 1H). 13C NMR
(100 MHz, CDCl3) δ: = 30.1, 112.8, 114.8, 114.9, 115.7,
115,8, 124.8, 127.1, 127.8, 127.9, 128.0, 129.1, 129.5,
129.8, 129.9, 131.9, 136.4, 161.3, 163.8. MS: m/z= 319
[M+].
3-Benzyl-2-(3-nitrophenyl)imidazo[1,2-a]pyri-
dine (3a). M.p. 121–124 °C; FT-IR (KBr) ν: 3065, 2926,
1
1651, 1627, 1527 cm−1; H NMR (400 MHz, CDCl3) δ:
3 Result and Discussion
4.40 (s, 2H), 6.76 (t, J=4 Hz, 1H), 7.03 (d, J=8 Hz, 2H),
7.19–7.25 (m, 4H), 7.47 (d, J = 4 Hz, 2H), 7.72 (s, 1H),
7.83 (s, 1H),8.09 (d, J=8, 1H), 8.50 (s, 1H) ppm;13C NMR
(100 MHz, CDCl3) δ: = 29.7, 113.5, 115.3, 122.7, 122.9,
127.3, 127.7, 128.0, 128.7, 129.3, 129.4, 132.1, 135.8,
147.9. MS: m/z=329.36 [M+].
Through the synthesis of imidazopyridines, the efect of
PEA-PSA@CuI as a catalyst was investigated in the synthe-
sis of 3-benzyl-2-phenylimidazo[1,2-a]pyridine (4a) as the
model compound. At frst, we investigated the efect of dif-
ferent amounts of the catalyst on the reaction progress in the
model reaction (Table 1, entries 1–3). Results of our studies
indicated the formation of the highest yield using 3.5 mol%
of the catalyst (Table 1, entry 1). It is worth mentioning
3-Benzyl-2-phenylimidazo[1,2-a]pyridine (4a). M.p.
118–121 °C [24]; FT-IR (KBr) ν: 3029, 2946, 1635, 1623,
1
1 3